# Effect of Immunosuppression in IgA Nephropathy

> **NCT03468972** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 174 (estimated)

## Conditions studied

- Biopsy-proven IgA Nephropathy

## Interventions

- **DRUG:** Immunosuppressive treatment
- **OTHER:** intensive supportive care

## Key facts

- **NCT ID:** NCT03468972
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468972, "Effect of Immunosuppression in IgA Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03468972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*